Abstract
Bis((1,4-dimethyl-9H-carbazol-3-yl)methyl)amine (DMCM) has been designed as a novel anti-cancer agent which is believed to have a sequence-specific groove binding interaction with DNA, leading to anticancer effects.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have